Abstract
Dantrolene is the drug of choice for the treatment of malignant hyperthermia (MH) and is also useful for treatment of spasticity or muscle spasms associated with several clinical conditions. The current study examines the mechanisms of dantrolene's action on skeletal muscle and shows that one of dantrolene's mechanisms of action is to block excitation coupled calcium entry (ECCE) in both adult mouse flexor digitorum brevis fibers and primary myotubes. A second important new finding is that myotubes isolated from mice heterozygous and homozygous for the RyR1 R163C MH susceptibility mutation show significantly enhanced ECCE rates that could be restored to those measured in wild type (WT) cells after exposure to clinical concentrations of dantrolene. We propose that this gain of ECCE function is an important etiological component of MH susceptibility and possibly contributes to the fulminant MH episode. The inhibitory potency of dantrolene on ECCE found in wild type and MH susceptible muscle is consistent with the drug's clinical potency for reversing the MH syndrome, and is incomplete as predicted by its efficacy as a muscle relaxant.
This article has not been copyedited and formatted. The final version may differ from this version. (Gronert, 2004; Krause et al., 2004) and animals (Bjurström, 1995; Klont et al., 1994; Nelson, 1991; Roberts et al., 2001) . MH is associated with acute increase in intracellular Ca 2+ (Reulbach et al., 2007) resulting from exposure to volatile anesthetics and/or depolarizing muscle blockers (Ali et al., 2003; Gronert, 2004; Krause et al., 2004) .
Heat stress has also been clearly shown to trigger fulminant MH in susceptible mice (Chelu et al., 2006; Yang et al., 2006) , although its etiological role in human MH and MH in other species is debated (Robinson et al., 2003) . Dantrolene is also clinically useful for treatment of spasticity or muscle spasms associated with several clinical conditions including spinal cord injuries, stroke, multiple sclerosis, and cerebral palsy (Chou et al., 2004; Dressler and Benecke, 2005; Saulino and Jacobs, 2006; Verrotti et al., 2006) .
Dantrolene has been used successfully to mitigate symptoms arising from neuroleptic malignant syndrome (NMS) (Lappa et al., 2002; Strawn et al., 2007) , but meta-analysis of 271 case reports has indicated an overall higher mortality rate when dantrolene monotherapy is used to treat NMS (Reulbach et al., 2007) . The muscle relaxant properties single muscle twitch by 70%-75% (Flewellen et al., 1983) . Recent simulations of dantrolene's pharmacokinetic profile indicate that the European recommendations for treating MH result in 24 h plasma concentrations of 14 -18 mg/L (45-57 µM), whereas MHAUS guidelines result in plasma concentrations ranging from 7-23 mg/L (22.5-73µM) (Podranski et al., 2005) .
The plasma concentrations of dantrolene needed to successfully treat clinical MH (Podranski et al., 2005) , and those required to attenuation contractile force (1-10µM) (Krause et al., 2004) , suggest that this drug may influence multiple homeostatic mechanisms that affect not only Ca 2+ release from sarcoplasmic reticulum (SR) but also Ca 2+ entry into the muscle cell. Whether all the effects of dantrolene on attenuating myoplasmic Ca 2+ are mediated through a common pathway is not clear. The prevailing data support a view that ryanodine receptor type 1 (RyR1) is a direct and selective molecular target of dantrolene's muscle-relaxant action. RyR1 is the calcium release channel of sarcoplasmic reticulum that is essential for normal excitation-contraction (EC) coupling in skeletal muscle. defined by the authors as domain peptide 1 (DP1) (El-Hayek et al., 1999) . One mechanism proposed for dantrolene's inhibitory activity is through the stabilization of the interactions of two RyR1 domains AA 590-609 and AA 2442-2477. The second domain had also been
This article has not been copyedited and formatted. The final version may differ from this version. proposed that dantrolene stabilizes DP1-DP4 interactions in a manner that prevents the "unzipping" of these domains; a process that has been theorized to be necessary for transitioning from the closed to the open channel state; and thereby stabilizing the closed state of RyR1 channels (Kobayashi et al., 2005; Yamamoto et al., 2000; Yamamoto and Ikemoto, 2002a; Yamamoto and Ikemoto, 2002b) . MH mutations within DP1 or DP4 had been suggested to act by destabilizing the closed channel state and contribute to MH susceptibility (Murayama et al., 2007) . However no direct evidence has been presented to confirm either of these theories.
Attempts to demonstrate that the mechanism of dantrolene's action in both normal (Fruen et al., 1997; Zhao et al., 2001 ). However Szentesi and coworkers failed to inhibit the gating activity of RyR1 channels incorporated into bilayer lipid membranes (BLM) in the presence or absence of ATP (Szentesi et al., 2001 to humans and animals in vivo when RyR1 channel activity is very low (Lopez et al., 1985; Lopez et al., 1987; Lopez et al., 2000; Lopez et al., 1992; Lopez et al., 1990) . In addition,
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Methods

Preparation of primary myotubes
Primary skeletal myoblast lines were isolated from 1-to 2-day old C57/B6 wild type (WT) mice and from newborn mice heterozygous (HET) and homozygous (HOM) for point mutation R163C-RyR1 MH (Yang et al., 2006) as previously described (Cherednichenko at al., 2004; Hurne et al., 2005; Rando and Blau, 1997) . The myoblasts were expanded in 10 cm cell-culture treated Corning dishes coated with collagen (Calbiochem, Richmond, CA) and were plated onto 96-well µ-clear plates (Greiner) coated with MATRIGEL (Becton Dickinson) for Ca 2+ imaging studies. Upon reaching ~80% confluence, growth factors were withdrawn and the cells allowed to differentiate into myotubes over a period of 3 days .
Preparation of FDB fibers
Flexor digitorum brevis (FDB) muscles were dissected from adult mice (C57/B6) and single intact FDB myofibers were enzymatically isolated as previously described (Brown et al., 2007) . Following isolation, FDB's were plated on ECM (Sigma) coated glass bottom imaging dishes (Matek) and maintained in DMEM (GIBCO) supplemented with 0.2% BSA and 100 mM gentamicin (Sigma). Fibers were kept overnight in a 5% CO 2 incubator and experiments were conducted within 12-24 hours of plating. Dishes of myofibers were randomized to control treatment (0.1% DMSO), ryanodine (Calbiochem) treatment (250µM, ~ 1 hour), or ryanodine treatment followed by a 10 min application of dantrolene (10µM). were applied using two platinum electrodes fixed to opposite sides of the well and connected to an AMPI Master 8 stimulator set at 3V, 25ms bipolar pulse duration, over a range of frequencies (0.05-20 Hz; ~40 sec pulse train duration). Alternatively, higher frequency stimuli were applied to the cells at 30 Hz for 1.5 sec (7V; 1ms bipolar pulse duration) as described above and fluo-4 fluorescence emission from individual cells was measured at 100Hz using photometry (PTI, model 614). In some experiments, KCl was focally applied for 2 sec to depolarize the cells using Multivalve Perfusion System (Automate Scientific Inc., Oakland, CA). When K + (40mM) was applied the concentration of Na + was lowered accordingly to preserve osmolarity in the external medium.
Ca
Mn 2+ influx into myotubes was measured as previously described, or with minor modification (Clementi et al., 1992; Fessenden et al., 2000) . 
Reagents
Dantrolene sodium, calmodulin, and FKBP12 were obtained from Sigma-Aldrich. Fura-2 AM and Fluo-4 AM were obtained from Molecular Probes. Dantrolene was dissolved in dried DMSO (HPLC grade). All other reagents were of the highest purity commercially available.
Results and Discussion
Dantrolene suppresses electrically evoked Ca 2+ transients but does not directly inhibit RyR1 in BLM
We assessed if dantrolene (10µM) could depress the amplitude of Ca Figure 1 (panels A&B) showed that the maximum amplitudes of the triggered Ca 2+ transients were depressed by 18+5% within 10 min of dantrolene application (p<0.05), and that this effect was completely reversed within 10 min of wash-out with the same external medium lacking the drug (Fig. 1 A&C) . Dantrolene under these experimental conditions did not significantly (p>0.1) influence either the initial rate of rise ( Fig. 1 B) , 1997) . The fourth and fifth traces in Figure 2B showed that, under these conditions, addition of CaM (1 µM) to the cis chamber rapidly enhanced channel Po as a result of prolonging τ o1 and shortening τ c (traces 4 and 5). Subsequent addition of 10 and 20 µM dantrolene to the cis chamber failed to diminish channel gating parameters over the 20 min of recording (traces 6 and 7), although the channel remained responsive to addition of ryanodine and ruthenium red to the cis chamber ( Fig 2B, bottom traces) .
Collectively the data presented in Figures 1 and 2B suggest that dantrolene is unlikely to directly interact with the minimal functional unit of the channel complex (i.e., the FKBP12-RyR1-CaM complex) to attenuate the gating activity of the Ca 2+ release channel, even when measurements are made at physiological temperatures for mammalian skeletal This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 3) .
Dantrolene suppresses ECCE elicited by electrical pulse trains or KCl depolarization
Since dantrolene failed to have measurable effect on the gating activity of purified reconstituted FKBP12-RyR1-CaM channels or on SR depletion-activated SOCE, we next tested whether or not dantrolene may inhibit ECCE. Using the Mn 2+ quench technique with fura-2 loaded WT myotubes, the quench of fura-2 fluorescence was measured before (Fig. 4 trace "Ctrl") and during electrical stimulation with 20 Hz electrical pulse trains lasting ~40 s in a nominally Ca 2+ free external buffer containing 500 µM Mn 2+ . Under these assay conditions, electrical stimulation of the cells resulted in rapid enhancement of the rate of Mn 2+ quench of fura-2 that we attribute to ECCE (Fig. 4A) . If cells were pre-incubated with 10 µM dantrolene for 10 min prior to applying the electrical pulse train, the initial rate of Mn 2+ quench was reduced by 72+4% (p<0.001).
Ryanodine has been previously shown to transiently activate then persistently block RyR1 channel activity in a concentration and time-dependent manner (Pessah and Zimanyi, 1991) . Pretreatment of RyR1 with ryanodine in intact myotubes has been shown to accentuate ECCE by slowing its inactivation/deactivation (Cherednichenko at al., 2004; Hurne et al., 2005) . In the present study, we pre-treated myotubes with 500 µM ryanodine for 30 min. Under these conditions, the cells failed to respond to 20 mM caffeine (data not shown), indicating that ryanodine blocked RyR1 activity. Never the less, stimulation of the same cells with a 20Hz pulse train resulted in a large Ca 2+ transient, which we attributed to the rapid entry of extracellular Ca 2+ into the cells via ECCE (Fig 5A) . Dantrolene inhibited ECCE in ryanodine-pretreated myotubes in a dose dependent manner with an IC 50 of 4.2
This article has not been copyedited and formatted. The final version may differ from this version. +1.9 µM but failed to completely inhibit ECCE, reaching a maximum inhibition of 69% of the control rate between 10 and 50 µM dantrolene (Fig. 5A, inset) . Dantrolene also inhibited the rate of Mn 2+ quench triggered by electrical pulse trains delivered to cells not pretreated with ryanodine in an external medium containing 500 µM Mn 2+ and nominally free of Ca 2+ with a similar dose-response characteristic as ryanodine pre-treated cells tested for ECCE (Fig. 5B vs. 5A, respectively).
ECCE in FDB fibers is inhibited by dantrolene
The existence of ECCE in adult skeletal muscle fibers has not been directly investigated previously. We therefore performed experiments with adult FDB skeletal muscle fibers (FDBs) dissected from WT adult mice as described in Methods. Figure 6A shows Fig   6C , bar labeled Ctrl) in response to depolarization. Ryanodine pre-treated FDBs were exposed to dantrolene (10 µM) 10 min prior to testing for ECCE. As would be predicted from our results with myotubes, dantrolene reduced the rate of Mn 2+ -mediated fura-2 quench by 62% compared to cells exposed to ryanodine alone (n=19; p<0.001; Fig 6B, Figure 6A and C) , although the variance associated with these measurements necessitates a larger number of fibers be tested to obtain sufficient statistical power.
Enhanced ECCE in myotubes expressing R163C-RyR1 is restored by dantrolene
To determine whether or not dantrolene's effects on ECCE were relevant to its ability to prevent or treat MH, myotubes prepared from WT, HET, and HOM R163C-RyR1 mice were tested for their rates of Mn 2+ quench elicited by 20 Hz electrical pulses described above and the effects of dantrolene on these quench rates. In these experiments the extracellular Mn 2+ was set at 500 µM, but instead of the nominally Ca 2+ -free external solution used in experiments shown in Fig. 4 It is well established that exposure of mice to ryanodine and its derivatives triggers hyper-contraction of skeletal muscle with rapid onset that is invariably lethal (Waterhouse et al., 1987) . To date skeletal muscle hyper-contraction elicited by ryanodine has been interpreted as being solely the result of stabilizing a persistent open state of RyR1 (Meissner, 2002) . However, ryanodine has been shown to stabilize multiple RyR1 channel conductance states, and predominating among them is a highly stable fully closed state (Bidasee et al., 2003; Buck et al., 1997; Zimanyi et al., 1992) . The novel observation reported here is that the ryanodine-modified RyR1 state in which ryanodine completely locks the RyR1 channel in a non-conducting conformation greatly enhances ECCE in myotubes and adult fibers, suggesting a potentially important role for Ca of ryanodine have been documented to be dependent on the activity of the EC coupling elicited by transverse (T) tubule depolarization (Hillyard and Procita, 1959; Procita, 1956; Procita, 1958) . Moreover evidence for the role of ECCE in normal use-dependent physiology and pathophysiology of adult skeletal muscles may have been described in earlier studies, but underappreciated. For example the rate of relaxation of contractures after prolonged applications of extracellular K + was faster in the absence of extracellular Ca 2+ than in its presence (Caputo and Gimenez, 1967) , whereas brief depolarization in Ca 2+ free solutions was not different than the response in Ca 2+ replete external medium (Caputo and Gimenez, 1967; Grabowski et al., 1972) . More recently, age-related denervation of fast skeletal muscle was found in senescent mice, and muscle fibers isolated from them were found to show dependence on extracellular Ca 2+ to maintain tetanic force (Payne et al., 2007) .
Results from the present study also identify ECCE as a target of dantrolene's pharmacological actions in both FDBs and myotubes prepared from WT mice. The potency (IC 50 = 4 µM) and limited maximum efficacy (60-70% diminution) of dantrolene toward attenuating ECCE is consistent with its pharmacological activity as a muscle relaxant. The efficacy of 10 µM dantrolene towards attenuating ECCE is similar in naïve and ryanodineexposed preparations in both models, suggesting that a common mechanism is involved.
Collectively these results confirm that myotubes represent a predictive and useful model of adult fibers in which to study physiological, pathophysiological and pharmacologic processes associated with ECCE. Dantrolene's inhibitory activity could be measured in both native and ryanodine-treated myotubes by monitoring either Mn 2+ (Figs. 4 & 5B) or Ca 2+ (Fig. 5A) when the Ca 2+ concentration in the external buffer is raised from nominally free Ca 2+ (Fig.   4 ) to one that contains 300 µM Ca 2+ ( Fig. 7 and 8) . As a skeletal muscle relaxant dantrolene is active in the dose range of 1-10 µM and it produces a maximum of 60-70% attenuation of contractile force (Gronert, 2004; Krause et al., 2004) .
Measurements of RyR1 channel gating kinetics in the BLM preparation have previously failed to support (Szentesi et al., 2001 ) the biochemical evidence that is the basis for the hypothesis that the muscle relaxant properties of dantrolene result from a direct interaction with RyR1 domains that stabilize the closed conformation of the channel , 1997; Zhao et al., 2001 We have previously shown that point mutations C4958S and C4961S changes in the conformation of these Ca 2+ channels to a persistent inactive state that can in turn influence ECCE inactivation/deactivation (Hurne et al., 2005) . Similar influences on ECCE were reported in ryanodine pre-treated myotubes (Cherednichenko et al., 2004) . In the present paper, we demonstrate enhanced ECCE in R163C HET and HOM myotubes that could be reduced by 10µM dantrolene to a rate similar to that seen in naïve WT cells. It The rates of Mn 2+ quench of fura-2 during depolarization with K + were normalized to the quench rate before depolarization of each fiber. ANOVA revealed that mean rates were significantly enhanced after depolarization compared to before depolarization for each treatment group (*= p<0.05). 
